NewsBenzingaMorgan Stanley Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $40 Morgan Stanley Maintains Overweight on Keurig Dr Pepper, Raises Price Target to $40 Benzinga 2026.11.04 18:12 (GMT+0) Open on Benzinga Other news 'Meta Acquires AI Coding Startup Conductor' - Axios Exclusive Morgan Stanley Maintains Equal-Weight on Upstart Holdings, Lowers Price Target to $24 Morgan Stanley Maintains Equal-Weight on Ultragenyx Pharmaceutical, Raises Price Target to $22 CAVA Earnings Preview: Kalshi Traders Bet on Cyclospora Talk as Sales Recovery Faces Test Waymo confirms it will split with Uber in January 2028 Morgan Stanley Maintains Equal-Weight on Gartner, Raises Price Target to $192
